RecruitingNot ApplicableNCT07491601

PRESS -PAR: Early Detection and PREvention of Symptomatic postSurgical hypoPARathyroidism After Thyroid Surgery"

Sponsor

Nicolas Schlegel

Enrollment

336 participants

Start Date

Jan 8, 2025

Study Type

INTERVENTIONAL

Conditions

Hypoparathyroidism Post-surgical Postoperative Hypoparathyroidism Postsurgical Hypoparathyroidism

Summary

This study aims to investigate whether an earlier measurement of parathyroid hormone can reduce the number of patients who develop symptomatic hypoparathyroidism. This will provide evidence for a clear algorithm to address this issue after thyroid surgery. It will lead to an improvement in quality of life and a reduction in the distress experienced by affected patients. In addition, it is conceivable that patients' hospital stay could be shortened.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Active vitamin D and a drug called Calcium for people with hypoparathyroidism post-surgical, postoperative hypoparathyroidism, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.